JP2010534225A5 - - Google Patents

Download PDF

Info

Publication number
JP2010534225A5
JP2010534225A5 JP2010517434A JP2010517434A JP2010534225A5 JP 2010534225 A5 JP2010534225 A5 JP 2010534225A5 JP 2010517434 A JP2010517434 A JP 2010517434A JP 2010517434 A JP2010517434 A JP 2010517434A JP 2010534225 A5 JP2010534225 A5 JP 2010534225A5
Authority
JP
Japan
Prior art keywords
composition according
day
skin
hyaluronic acid
daltons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2010517434A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010534225A (ja
Filing date
Publication date
Priority claimed from FR0705349A external-priority patent/FR2919185B1/fr
Application filed filed Critical
Publication of JP2010534225A publication Critical patent/JP2010534225A/ja
Publication of JP2010534225A5 publication Critical patent/JP2010534225A5/ja
Ceased legal-status Critical Current

Links

JP2010517434A 2007-07-23 2008-07-04 皮膚、眼および粘膜の保護機能改善用組成物を製造するためのヒアルロン酸の使用 Ceased JP2010534225A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0705349A FR2919185B1 (fr) 2007-07-23 2007-07-23 Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
PCT/FR2008/000959 WO2009024677A2 (fr) 2007-07-23 2008-07-04 Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de la fonction de protection de la peau, de l'oeil et des muqueuses

Publications (2)

Publication Number Publication Date
JP2010534225A JP2010534225A (ja) 2010-11-04
JP2010534225A5 true JP2010534225A5 (enExample) 2011-08-18

Family

ID=39088885

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517434A Ceased JP2010534225A (ja) 2007-07-23 2008-07-04 皮膚、眼および粘膜の保護機能改善用組成物を製造するためのヒアルロン酸の使用

Country Status (9)

Country Link
US (1) US8895532B2 (enExample)
EP (1) EP2167102B1 (enExample)
JP (1) JP2010534225A (enExample)
KR (1) KR20100059786A (enExample)
CN (1) CN101801391B (enExample)
BR (1) BRPI0814446A2 (enExample)
ES (1) ES2588190T3 (enExample)
FR (1) FR2919185B1 (enExample)
WO (1) WO2009024677A2 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010003797A1 (en) * 2008-07-09 2010-01-14 Novozymes Biopharma Dk A/S Hyaluronic acid for corneal wound healing
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
RU2740454C2 (ru) 2011-06-03 2021-01-14 Аллерган Эндюстри, Сас Составы кожного наполнителя, включая антиоксиданты
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
PT2543357T (pt) * 2011-07-07 2018-04-30 Holy Stone Healthcare Co Ltd Resumo
TWI466675B (zh) * 2011-09-16 2015-01-01 Univ China Medical 用於抑制發炎之醫藥組合物
CN102669681A (zh) * 2012-06-09 2012-09-19 东莞市照燕生物科技有限公司 一种保护胃肠粘膜的营养保健品
ES2627868T3 (es) 2012-10-25 2017-07-31 Mdt Int'l S.A. Composiciones mucoadhesivas que comprenden ácido hialurónico y quitosano para aplicación tópica
JP2015063510A (ja) * 2013-06-28 2015-04-09 キユーピー株式会社 肌の保湿機能向上に関わる保湿関連遺伝子発現促進剤
CN108024947A (zh) 2015-07-27 2018-05-11 玫琳凯有限公司 局部皮肤用制剂
JP6718728B2 (ja) * 2016-04-06 2020-07-08 キユーピー株式会社 アンチポリューション剤およびアンチポリューション用皮膚外用組成物
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
WO2022236599A1 (zh) * 2021-05-10 2022-11-17 傅毓秀 玻尿酸用于制备治疗急性呼吸窘迫症药剂的用途
TWI816119B (zh) * 2021-05-10 2023-09-21 國立陽明交通大學 玻尿酸用於製備治療急性呼吸窘迫症藥劑之用途
CN115317504A (zh) * 2021-05-10 2022-11-11 傅毓秀 玻尿酸用于制备治疗急性呼吸窘迫症药剂的用途
WO2022236585A1 (zh) * 2021-05-10 2022-11-17 傅毓秀 玻尿酸用于制备治疗肺纤维化药剂的用途
JP2024540319A (ja) 2021-11-05 2024-10-31 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 肺粘膜炎症の処置のための低分子量ヒアルロン酸の使用
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof
WO2024194437A1 (en) * 2023-03-22 2024-09-26 Institut National de la Santé et de la Recherche Médicale Use of low molecular weight hyaluronic acid for promoting ciliated cell differentiation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
US5166331A (en) * 1983-10-10 1992-11-24 Fidia, S.P.A. Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
JPS59219209A (ja) * 1983-05-28 1984-12-10 Kanebo Ltd 皮膚化粧料
IT1260148B (it) * 1992-04-17 1996-03-28 Fidia Spa Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
DE10111165A1 (de) * 2001-03-02 2002-10-10 Knoell Hans Forschung Ev Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen
DE10161149B4 (de) 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
DE10161110A1 (de) * 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
US7241456B2 (en) * 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use
FR2847818B1 (fr) * 2002-11-28 2008-04-04 Agro Ind Rech S Et Dev Ard Composition pharmaceutique a base d'acide hyaluronique
WO2006072243A1 (en) * 2005-01-03 2006-07-13 Novozymes Biopolymer A/S Hyaluronic acid fraction with moisturizing and anti-wrinkle properties
JP4576583B2 (ja) * 2005-03-22 2010-11-10 キユーピー株式会社 ヒアルロン酸またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物

Similar Documents

Publication Publication Date Title
JP2010534225A5 (enExample)
JP2009544722A5 (enExample)
US10758561B2 (en) Composition based on xyloglucan and proteins for the treatment of intestinal disorders
JP2010520246A5 (enExample)
JP2010515682A5 (enExample)
ME02448B (me) Upotreba streptococcus salivarius u liječenju hroničnih infekcija respiratornog trakta
WO2012000377A1 (zh) 包含左卡尼汀和羟苯磺酸盐的药物组合物
US20230331792A1 (en) New multi-functional oligopeptides
EP2251016A3 (en) Topical use of hyaluronic acid with folmogenic action for the treatment and prophylaxys of pathologies of the respiratory tract.
KR101045368B1 (ko) 베타닌을 유효성분으로 포함하는 위장질환 예방 또는 치료용 조성물
US20230113836A1 (en) New conjugates of peptides and polysaccharide
US20150094266A1 (en) Xyloglucan and protein compositions for the treatment of intestinal disorders
CN103446165A (zh) 低聚古罗糖醛酸在制备预防和治疗酒精性肝损伤的药物、保健品或饮食补充剂中的应用
CN102698271A (zh) 一种降糖药物组合物及其应用
RU2013103051A (ru) Способ терапии бронхо-констриктивных состояний
Stancic-Rokotov et al. Lung lesions and anti-ulcer agents beneficial effect: Anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats
CN105085455A (zh) 唾液酸类似物或其药学上可接受的盐及其应用
NO20083213L (no) Farmasoytisk sammensetning inneholdende montelukast
US20140364390A1 (en) Xyloglucan-based compositions for the treatment of gastrointestinal disorders
CN102276590B (zh) 一种金线莲提取物自旋标记类似物及制备与用途
DK2288342T3 (en) MAGNESIA SYSTEM AND ITS APPLICATION IN THE COSMETICS INDUSTRY
CN107582430A (zh) 一种青稞β‑葡聚糖‑聚天冬氨酸复合物的制备和应用方法
CN106243102B (zh) 生物碱类化合物的应用
IT201800006400A1 (it) Composizione per le patologie gastriche ed esofagee
CN107158005B (zh) 救必应酸在制备抗流感病毒药物中的应用